摘要
随着循证医学在我国的逐步发展,循证医学理念深入人心。中医药领域在吸收借鉴循证医学循证及其相关学科的研究方法和成果,并结合中医药自身特点的基础上,逐步形成了循证中医药学并取得了显著发展。中医药系统评价作为循证中医药学的主要任务之一,也正受到越来越多的关注。虽然每年发表的中医药系统评价也不断增加,但研究质量参差不齐,仍需进一步提高。鉴于中医药诊治过程的复杂性,疗效评价指标的主体性,并结合现实需要,本文就以常用有毒中药附子为例,探讨在中医药系统评价的实践过程中可能面临的问题及可能的应对办法,为开展中医药系统评价提供借鉴,推动循证中医药学的发展。
With the gradual development of evidence-based medicine(EBM) in China, the concept of EBM has been widely accepted. On the basis of the research methods and achievements of EBM and its related disciplines, and combining with the characteristics of traditional Chinese medicine(TCM), TCM EBM has gradually formed and made remarkable progress. As one of the main tasks of evidence-based Chinese medicine, systematic evaluation of TCM is attracting more and more attention. Although the published systematic evaluation of TCM every year is increasing, the quality of research is uneven and still needs further improvement. Because of the complexity of the process of diagnosis and treatment of TCM, subjective evaluation of curative effect, and the needs in practice, the common problems and possible responses in the process of the practice of systematic review of TCM are explored, with the common toxic Chinese medicine herbs as example, which may be served as a reference for system evaluation of TCM and promote the modernization of TCM.
作者
梁洁
秦天强
潘校琦
刘蜀坤
吴丽娟
LIANG Jie;QIN Tian-qiang;PAN Xiao-qi;LIU Shu-kun;WU Li-juan(Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan)
出处
《中药与临床》
2019年第2期27-29,共3页
Pharmacy and Clinics of Chinese Materia Medica
基金
成都中医药大学科技发展基金（ZRQN1709）
国家自然科学类基金青年基金（81603537）
关键词
循证医学
循证中医药学
中医药系统评价
附子
Evidence-based medicine
evidence-based Chinese medicine
systemic evaluation of traditional Chinese medicine
Fuzi
